Ligand validation:5L8D

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5L8D_GOL_B_604	82%	66%	0.102	0.957	0.52	0.77	-	-	2	0	100%	1
5L8D_GOL_B_603	50%	36%	0.139	0.89	0.94	1.55	-	2	1	0	100%	1
5L8D_GOL_A_606	47%	51%	0.148	0.888	0.57	1.32	-	-	0	0	100%	1
5L8D_GOL_A_613	38%	40%	0.156	0.856	0.94	1.39	-	1	1	0	100%	1
5L8D_GOL_A_605	34%	66%	0.191	0.875	0.71	0.62	-	-	1	0	100%	1
5L8D_GOL_A_616	33%	70%	0.172	0.852	0.34	0.8	-	-	0	0	100%	1
5L8D_GOL_B_602	18%	54%	0.213	0.802	0.52	1.24	-	-	1	0	100%	1
5L8D_GOL_A_607	13%	65%	0.189	0.729	0.75	0.59	-	-	1	0	100%	1
5L8D_GOL_B_614	9%	41%	0.262	0.755	1.11	1.17	-	-	8	0	100%	1
5L8D_GOL_B_609	2%	77%	0.348	0.64	0.39	0.53	-	-	0	0	100%	1
5L8D_GOL_A_615	1%	73%	0.32	0.532	0.33	0.71	-	-	0	0	100%	1
5L8D_GOL_A_614	1%	66%	0.322	0.494	0.58	0.72	-	-	0	0	100%	1
5ON9_GOL_B_603	94%	89%	0.071	0.97	0.35	0.3	-	-	0	0	100%	1
3MVW_GOL_A_513	90%	67%	0.078	0.961	0.72	0.56	-	-	0	0	100%	1
4I9D_GOL_A_603	84%	71%	0.088	0.948	0.3	0.8	-	-	1	0	100%	1
5MWU_GOL_B_604	82%	66%	0.102	0.957	0.52	0.77	-	-	2	0	100%	1
5ON0_GOL_B_606	79%	88%	0.102	0.947	0.39	0.29	-	-	1	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.